Adam Grossman is the CEO of ADMA Biologics, a biopharmaceutical company focused on developing and manufacturing plasma-derived products. With over 25 years of experience in the blood and plasma industry, Grossman has been instrumental in transforming ADMA Biologics into a vertically integrated plasma products manufacturer. His leadership has driven significant growth and development for the company, including successful regulatory approvals and strategic acquisitions.
Who is the CEO of ADMA Biologics?
With a robust background in the biopharmaceutical industry, Adam Grossman stands as the CEO, President, and Founder of ADMA Biologics. Grossman's career spans over 25 years, during which he has held pivotal roles, including President and Chief Operating Officer at ADMA Biologics and Executive Vice President at National Hospital Specialties and GenesisBPS. His extensive experience also includes significant tenures at MedImmune, Inc. and the American Red Cross. Under his leadership, ADMA Biologics has achieved substantial milestones, including going public in 2013 and securing FDA approvals for key products.
Grossman's vision and hands-on approach have been instrumental in transforming ADMA Biologics into a vertically integrated plasma products manufacturer, addressing critical medical needs for immune-compromised patients.
Work History
Adam Grossman's work history includes a diverse range of roles in the biopharmaceutical and healthcare industries. Here is a summary of his previous positions:
- ADMA Biologics - CEO, President, and Founder (2012 - Present)
- ADMA Biologics - President and Chief Operating Officer (2007 - 2012)
- National Hospital Specialties - Executive Vice President (2005 - 2007)
- GenesisBPS - Executive Vice President (2003 - 2005)
- MedImmune, Inc. - Various Roles (2000 - 2003)
- American Red Cross - Various Roles (1998 - 2000)
Education History
Adam Grossman holds a B.S. in Business Administration with a specialization in International Business and Marketing from American University. His educational background laid a strong foundation for his extensive career in the biopharmaceutical and healthcare industries. The knowledge and skills acquired during his academic journey have been pivotal in his roles, from founding ADMA Biologics to serving as Executive Vice President at GenesisBPS. Grossman's education has equipped him with the expertise needed to navigate the complexities of the industry and drive significant growth and innovation.
When did Adam Grossman join ADMA Biologics?
Adam Grossman founded ADMA Biologics in 2007, marking the beginning of his journey with the company. He has served as the President and Chief Executive Officer since October 2011. With a tenure spanning over 16 years, Grossman has been pivotal in steering the company through significant milestones and growth phases. His leadership has been instrumental in transforming ADMA Biologics into a vertically integrated plasma products manufacturer, addressing critical medical needs for immune-compromised patients.